Join
Live feed
·
SECFilingvia Quantisnow
Sorrento Therapeutics Inc. logo

Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

ByQuantisnow·Wall Street's wire, on your screen.
SRNE· Sorrento Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SRNE (Sorrento Therapeutics Inc.) and more on Quantisnow.